CIK 0001699031 · Non-accelerated filer<br>Emerging growth company
GRAIL, Inc.
Sign in to watch- Ticker
- GRAL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863673636
- Phone
- (833) 694-2553
- Business address
- 250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
- Former names
- GRAIL, LLC
- 4 Grant or award Director acquired 396 shares (grant or award)
- 4 Grant or award Director acquired 408 shares (grant or award)
- 4 Grant or award Director acquired 631 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 45,806 shares at $49.92 ($2,286,526)
- 4 Open-market sale Chief Executive Officer sold 123,502 shares at $49.92 ($6,164,923)
- 4 Open-market sale President sold 61,665 shares at $49.92 ($3,078,169)
- 4 Open-market sale Chief Financial Officer sold 3,147 shares at an average $48.96 ($154,062)
- 4 Open-market sale President sold 3,627 shares at an average $48.86 ($177,227)
- 4 Open-market sale Chief Executive Officer sold 8,441 shares at an average $48.48 ($409,246)
- 4 Open-market sale President sold 17,002 shares at an average $50.16 ($852,848)
- 4 Open-market sale Chief Financial Officer sold 9,573 shares at an average $50.17 ($480,244)
- 4 Open-market sale Chief Executive Officer sold 37,504 shares at an average $50.17 ($1,881,417)
- 4 Grant or award Director acquired 213 shares (grant or award)
- 4 Grant or award Director acquired 329 shares (grant or award)
- 4 Grant or award Director acquired 206 shares (grant or award)
- 4 Open-market sale President sold 13,000 shares at $100.00 ($1,300,000)
- 4 Open-market sale Chief Executive Officer sold 40,000 shares at an average $95.24 ($3,809,535)
- 4 Open-market sale Chief Financial Officer sold 25,000 shares at $99.15 ($2,478,818)
- 4 Open-market sale Chief Financial Officer sold 1,697 shares at $79.20 ($134,402)
- 4 Open-market sale 10% owner sold 1,000,000 shares at $79.85 ($79,850,000)
Page 2 of 6 · 115 filings